CRP lacks optimal sensitivity and specificity, IL-6 lacks specificity for hematological malignancies despite its rapid post-infection rise, and PCT may be influenced by coexisting conditions like tumors and thyroid diseases [15, 16]. This evidence concerns the gene IL6 and infection.